New Hillary Clinton plan invests in research, makes cure to Alzheimer’s possible by 2025
With 5 million Americans suffering from Alzheimer’s today, and nearly 15 million expected to be affected by 2050, Hillary Clinton is launching a new, groundbreaking $2 billion annual commitment to prevent, effectively treat and make a cure possible for Alzheimer’s disease by 2025. Alzheimer’s is the 6th leading cause of death in the United States and is the only cause in the Top 10 that we cannot currently prevent, cure, or even slow.
Women and communities of color are uniquely affected by for this terrible disease. Two out of every three Alzheimer’s patients are women, older African Americans are twice as likely than older white individuals to be afflicted and older Latinos are 1.5 times as likely. Alzheimer’s is one of the costliest diseases in America – exceeding $200 billion in annual costs to the economy from the disease and related dementia. Recent reports suggest that by 2050 the total cost may exceed $1 trillion per year.
In developing this plan, Hillary Clinton has consulted with leading physician-scientists to understand what it would take to rapidly accelerate progress currently being made in the field. In the U.S. Senate, Clinton co-chaired the Congressional Task Force on Alzheimer’s disease.
“We owe it to the millions of families who stay up at night worrying about their loved ones afflicted by this terrible disease and facing the hard reality of the long goodbye to make research investments that will prevent, effectively treat and make a cure possible by 2025,” Clinton said. “The best scientific minds tell us we have a real chance to make groundbreaking progress on curing this disease and relieving the pain so many families feel every day. My plan will set us on that course.”
Clinton’s plan will
- Dedicate a historic, decade-long investment of $2 billion per year to Alzheimer’s research and related disorders – a fourfold increase over last year’s $586 million. Leading researchers including the research advisory council to the congressionally-authorized National Plan to Address Alzheimer’s Disease, have set out this goal of $2 billion a year to prevent and effectively treat Alzheimer’s and make a cure possible by 2025.
- Ensure a reliable stream of funding for fighting Alzheimer’s between now and 2025. This plan ensures predictability of funding between now and 2025, so that researchers can work consistently towards developing effective treatments and a cure. This gives researchers greater freedom to pursue the big, creative bets – including cross-collaboration with researchers in related fields – that can result in dramatic pay-offs.
- Appoint a top-flight team to oversee this initiative and consult regularly with top researchers to ensure progress towards achieving the treatment target. At each stage, this plan will embrace a range of approaches to drive new knowledge into effective treatments.
Clinton’s bold, new research investment in preventing and effectively treating Alzheimer’s will yield results not just in the fight against this disease, but for a range of neurodegenerative illnesses, from Parkinson’s disease to Lewy body dementia to frontotemporal dementia. The plan will also help medical professionals understand the intersection of Alzheimer’s with other conditions, including the high rate of individuals with Down syndrome who experience early-onset Alzheimer’s.
This commitment to Alzheimer’s research is only part of Clinton’s overall commitment to a substantial increase in investment at the National Institutes of Health to prevent, treat, and secure cures for the broad array of diseases that afflict Americans.
In addition to investing in research, Clinton announced today new parts of her agenda to support caregivers, like those who give critical care and support to the millions of families struggling with Alzheimer’s. Her plan will fight for Medicare to cover a comprehensive, care-planning session with a clinician following every new diagnosis of Alzheimer’s or related diseases, work with Congress to reauthorize the Missing Alzheimer’s Disease Patient Alert Program and direct the Social Security Administration to raise awareness of the Medicare-covered annual wellness visits and their associated preventive and screening benefits, including the cognitive screening – which is especially critical for patients suffering from Alzheimer’s and other related dementia, by presenting this information alongside Social Security payments that beneficiaries will open and read.
A full fact sheet on the new plan is available here.